Texto: 
Labs and visual field testing: Pending
Surgical resection.
Radiological Findings: 
-Large sellar mass with suprasellar extension.
-Isointense on T1, hyperintense T2, enhances intensely and heterogeneously
-Intrasellar expansion (ballooning of sella)
-Cavernous sinus involvement, no ICA involvement
Pituitary Macroadenoma
1.  Pituitary Macroadenoma
2.  Craniopharyngioma (Ca2+, mural nodule, fluid/fluid level, cystic regions)
3.  Rathke's cleft cyst (no enhancement)
4.  Meningioma (should be able to define pituitary)
50 y/o male with decreased libido.
No discrete pituitary gland is identified making a pituitary based lesion very likely.  The size being >1cm makes this a macroadenoma.  Mass effect usually make these lesions symptomatic.  These include hypopituitarism, visual symptoms from optic chiasm displacement (bitemporal hemianopsia is classic), other cranial nerve palsy (cavernous location of CNs III, IV, V-1, VI).  Macroadenomas can secrete hormonal subunits but are uncommonly functional (unlike microadenomas).

*Calcification in macroadenomas is uncommon (common in craniopharyngioma). Cystic regions, +/- fluid/fluid levels, mural nodule also seen in craniopharyngioma.
*Should be able to define pituitary gland in intrasellar extension of meningioma.
*Rathke's cleft cyst-doesn't enhance.


Keywords: 
\-\ define\\ pituitary\\ gland\ \(1\)\
\-\ pituitary\\ macroadenoma\\ 2\ \(0\)\
\-\ discrete\\ pituitary\\ gland\ \(1\)\
\-\ pituitary\\ based\\ lesion\ \(1\)\
\-\ define\\ pituitary\ \(2\)\
\-\ mural\\ nodule\\ also\\ seen\ \(1\)\
\-\ ca2\\ \\+\\,\\ mural\\ nodule\ \(0\)\
\-\ unlike\\ microadenomas\\ \\)\\.\ \(0\)\
\-\ mass\\ effect\\ usually\\ make\ \(0\)\
\-\ fluid\\ levels\ \(58\)\
\-\ fluid\\ level\ \(139\)\
\-\ craniopharyngioma\\ \\)\\.\ \(0\)\
\-\ \\+\\/\\-\\ fluid\ \(1\)\
\-\ visual\\ field\\ testing\ \(3\)\
\-\ vi\\ \\)\\.\ \(0\)\
\-\ large\\ sellar\\ mass\ \(0\)\
\-\ intrasellar\\ extension\ \(1\)\
\-\ fluid\ \(1015\)\
\-\ cavernous\\ sinus\\ involvement\ \(0\)\
\-\ visual\\ symptoms\ \(4\)\
\-\ suprasellar\\ extension\ \(4\)\
\-\ secrete\\ hormonal\\ subunits\ \(1\)\
\-\ pending\\ surgical\\ resection\ \(1\)\
\-\ optic\\ chiasm\\ displacement\ \(1\)\
\-\ intrasellar\\ expansion\ \(0\)\
\-\ cranial\\ nerve\\ palsy\ \(8\)\
\-\ cavernous\\ location\ \(1\)\
\-\ uncommonly\\ functional\ \(1\)\
\-\ radiological\\ findings\ \(11\)\
\-\ macroadenoma\ \(34\)\
\-\ lesions\\ symptomatic\ \(1\)\
\-\ include\\ hypopituitarism\ \(1\)\
\-\ identified\\ making\ \(1\)\
\-\ hyperintense\\ t2\ \(0\)\
\-\ enhances\\ intensely\ \(4\)\
\-\ decreased\\ libido\ \(2\)\
\-\ cystic\\ regions\ \(7\)\
\-\ craniopharyngioma\ \(24\)\
\-\ cns\\ iii\ \(0\)\
\-\ cleft\\ cyst\ \(44\)\
\-\ classic\\ \\)\\,\ \(0\)\
\-\ bitemporal\\ hemianopsia\ \(4\)\
\-\ 1cm\\ makes\ \(1\)\
\-\ v\ \(54359\)\
\-\ uncommon\ \(111\)\
\-\ t1\ \(2\)\
\-\ size\ \(626\)\
\-\ sella\ \(194\)\
\-\ rathke\ \(0\)\
\-\ meningioma\ \(167\)\
\-\ male\ \(2851\)\
\-\ macroadenomas\ \(6\)\
\-\ likely\ \(907\)\
\-\ labs\ \(154\)\
\-\ iv\ \(11085\)\
\-\ isointense\ \(102\)\
\-\ heterogeneously\ \(47\)\
\-\ enhancement\ \(862\)\
\-\ enhance\ \(1406\)\
\-\ common\ \(1495\)\
\-\ calcification\ \(842\)\
\-\ ballooning\ \(1\)\
\-\ able\ \(2982\)\
\-\ 50\ \(678\)\
\-\ 4\ \(7367\)\
\-\ 3\ \(8405\)\
\-\ 1\ \(15898\)\
